Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, Minnesota.
Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
J Minim Invasive Gynecol. 2022 Jul;29(7):884-890.e2. doi: 10.1016/j.jmig.2022.04.009. Epub 2022 Apr 25.
Compare the difference in postoperative morbidity for benign total hysterectomy by indication.
Retrospective cohort.
United States hospitals participating in the American College of Surgeons National Surgical Quality Improvement Project database from 2018 to 2019.
Patients undergoing total hysterectomy for benign indications age 18 to 55 years old.
Univariate comparisons were made between patients with hysterectomies for endometriosis and other benign indications. Unadjusted and adjusted logistic regression models were used to investigate the association between primary outcomes and hysterectomy indication; covariates in the adjusted model include age, race, ethnicity, and route.
A total of 29 742 women underwent hysterectomies, of which 3596 (12.1%) were performed for endometriosis. Patients undergoing hysterectomy for endometriosis were likely to be younger, were predominately White, and had less comorbidities. They were also more likely to have previous abdominal surgery, have previous pelvic surgery, undergo a laparoscopic approach, and undergo lysis of adhesions (all p <.001). Overall length of stay (≥1 day 73.1% vs 78.6%; p = .983) and operative time (median 118.0 vs 125.0 minutes; p <.001) were similar in both groups. Examining primary outcomes, patients with endometriosis were more likely to experience major morbidity (3.8% vs 3.4%; adjusted odds ratio [OR], 1.25; p = .033), with no difference in minor or overall morbidity (5.8% vs 6.9% [p = .874] and 8.8% vs 9.4% [p = .185], respectively). There were two 30-day mortalities, none in the endometriosis group. Patients with endometriosis were more likely to develop deep surgical site infection (SSI)/organ-space infection (2.3% vs 1.6%; OR, 1.42; p = .024) and less likely to receive blood transfusion (1.8% vs 3.0%; OR, 0.58; p <.001). There was no difference in occurrence of superficial SSI, sepsis, venous thromboembolism, readmission, or reoperation between groups.
Patients undergoing hysterectomy for endometriosis were more likely to experience major morbidity and deep SSI, although overall major morbidity is rare.
比较不同适应证行全子宫切除术的术后发病率差异。
回顾性队列研究。
2018 年至 2019 年期间,美国参与美国外科医师学会国家手术质量改进计划数据库的医院。
年龄 18 至 55 岁,因良性指征行全子宫切除术的患者。
对因子宫内膜异位症和其他良性指征行子宫切除术的患者进行单变量比较。使用未调整和调整后的逻辑回归模型来研究主要结局与子宫切除术适应证之间的关系;调整模型中的协变量包括年龄、种族、民族和途径。
共 29742 名女性接受了子宫切除术,其中 3596 名(12.1%)因子宫内膜异位症而行子宫切除术。因子宫内膜异位症行子宫切除术的患者更年轻,主要为白人,合并症更少。她们也更有可能接受过腹部手术、盆腔手术、腹腔镜入路和粘连松解术(均 p <.001)。两组的总住院时间(≥1 天的患者比例为 73.1% vs 78.6%;p =.983)和手术时间(中位数为 118.0 分钟 vs 125.0 分钟;p <.001)相似。检查主要结局,子宫内膜异位症患者发生严重发病率的可能性更高(3.8% vs 3.4%;调整后的优势比 [OR],1.25;p =.033),但轻微或总体发病率无差异(5.8% vs 6.9%[p =.874]和 8.8% vs 9.4%[p =.185])。有两例 30 天内死亡,均不在子宫内膜异位症组。子宫内膜异位症患者更有可能发生深部手术部位感染(SSI)/器官间隙感染(2.3% vs 1.6%;OR,1.42;p =.024),且不太可能接受输血(1.8% vs 3.0%;OR,0.58;p <.001)。两组之间的浅表 SSI、败血症、静脉血栓栓塞、再入院或再次手术的发生率无差异。
因子宫内膜异位症而行子宫切除术的患者发生严重发病率和深部 SSI 的可能性更大,尽管总体严重发病率较低。